Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic susceptibility to cerebral palsy involves complement system-mediated neuronal development and plasticity pathway. | Sci Rep | 2025 | 40594558 | PubTator, text mining | PubMed |
| Nonlytic Egress and Transmission in the Virus World. | Annu Rev Biochem | 2025 | 40540754 | PubTator, text mining | PubMed |
| Axl inhibitor-mediated reprogramming of the myeloid compartment of the in vitro tumor microenvironment is influenced by prior targeted therapy treatment. | Front Immunol | 2025 | 40539073 | PubTator, text mining | PubMed |
| Commentary: is trogocytosis relevant for chimeric antigen receptor-T cells? | Oncologist | 2025 | 40504546 | PubTator, text mining | PubMed |
| miR-1343-3p, mediated by LncRNA ASMTL-AS1, induces ferroptosis in osteosarcoma progression by targeting TYRO3. | Gene | 2025 | 40466961 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Biomarkers in Opioid Dependence: Evidence of Neuroimmune Activation and Ion Composition Changes, Without Alteration in Orexin-A. | Addict Biol | 2025 | 40454659 | PubTator, text mining | PubMed |
| Genes of the "regulation of lymphocyte activation" pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors. | Pituitary | 2025 | 40415137 | PubTator, text mining | PubMed |
| Prospects of current AXL-targeting therapies in early phase cancer trials. | Expert Opin Investig Drugs | 2025 | 40413629 | PubTator, text mining | PubMed |
| Structure-Based Design of Potent and Selective MerTK Inhibitors by Modulating the Conformation of αC Helix. | J Med Chem | 2025 | 40391976 | PubTator, text mining | PubMed |
| Critical role of alpha spectrin in DNA repair: the importance of μ-calpain and Fanconi anemia proteins. | Exp Biol Med (Maywood) | 2025 | 40375875 | PubTator, text mining | PubMed |
| Secular trends in body weight perception among Norwegian adolescents: a 28-year cross-sectional analysis (1994-2022). | Sci Rep | 2025 | 40374767 | PubTator, text mining | PubMed |
| Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma. | Clin Cancer Res | 2025 | 40353734 | PubTator, text mining | PubMed |
| Recent advances in TAM mechanisms in lung diseases. | J Transl Med | 2025 | 40287707 | PubTator, text mining | PubMed |
| Repurposing of the Syk inhibitor fostamatinib using a machine learning algorithm. | Exp Ther Med | 2025 | 40242601 | PubTator, text mining | PubMed |
| Discovery of Novel TYRO3/MERTK Dual Inhibitors. | J Med Chem | 2025 | 40215328 | PubTator, text mining | PubMed |
| Comprehensive Molecular and Genomic Analysis of NCI-MATCH Subprotocol Y: Capivasertib in Patients With an AKT1 E17K-Mutated Tumor. | JCO Precis Oncol | 2025 | 40153687 | PubTator, text mining | PubMed |
| UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor. | J Med Chem | 2025 | 40070132 | PubTator, text mining | PubMed |
| A single mutation in the PrM gene of Zika virus determines AXL dependency for infection of human neural cells. | J Virol | 2025 | 40062839 | PubTator, text mining | PubMed |
| Associations of sport and exercise participation in adolescence with body composition and device-measured physical activity in adulthood: longitudinal data from the Norwegian HUNT study. | Int J Behav Nutr Phys Act | 2025 | 40045311 | PubTator, text mining | PubMed |
| Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us? | Cell Death Dis | 2025 | 40044635 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=6